4D Molecular Therapeutics Inc
NASDAQ:FDMT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
4D Molecular Therapeutics Inc
NASDAQ:FDMT
|
US |
|
C
|
Coterra Energy Inc
DUS:XCQ
|
US |
|
Getty Realty Corp
F:GRL
|
US |
Multiples-Based Value
The Multiples-Based Value for
4D Molecular Therapeutics Inc (FDMT) under the Base Case is 6.94 USD.
Compared with the current market price of 14.97 USD, the stock appears
Overvalued by 54% .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.